Skip to main content
. 2017 Sep 30;15(1):12–16. doi: 10.5049/EBP.2017.15.1.12

Fig. 2. Course of treatment from diagnosis of anti-GBM disease to presentation of neurologic symptoms of PRES.

Fig. 2